Bratzler, Robert L.,Lipford, Grayson B.,Johnston, Lloyd,Zepp, Charles
申请号：
AU2017201145
公开号：
AU2017201145A1
申请日:
2017.02.20
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
#$%^&*AU2017201145A120170309.pdf#####ABSTRACT Disclosed are dosage forms and related methods, that include a first population of synthetic nanocarriers that have one or more first antigens coupled to them, one or more second antigens that are not coupled to the synthetic nanocarriers, and a pharmaceutically acceptable excipient. See Fig. 1.WO 2011/150264 PCT/US2011/038218 1/2 10000000 [ M2e EHA5 1000000u LU 100000...... Fig. 1 10000000 E] M2e SHA5 1F000000 LU 100000 K , 10000 Fig. 2
